On the upsideAlthough Royal Caribbean Cruises (NYSE: RCL) swung to a loss for the first quarter, the results were better than expected.
On the downside
Anadys Pharmaceutical (Nasdaq: ANDS) reported upbeat trial results for its hepatitis C treatment ANA598 but a number of patients developed rashes which prompted them to drop out of the studies while sparking safety concerns.
Old Republic International (NYSE: ORI) widened first quarter losses as revenue tumbled.
Bunge (NYSE: BG) swung to a first quarter loss as sales tumbled prompting the company to cut its full year guidance.
In the broad market, advancing issues outpaced decliners by a margin of 3 to 2 on the NYSE while decliners edged out advancers by nearly 5 to 3 on Nasdaq. The Russell 2000 which tracks small cap stocks lost 4 points to 466.